Drozitumab

Tax included
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma.
MedChemExpress 
HY-P99286

Data sheet

Size
Multiple sizes
Reactivity
Apoptosis
Application
Cancer-programmed cell death
CAS
912628-39-8